VRXAW Veraxa Biotech AG Warrants
$0.10▲ +0.00%
Unknown
Other
Volume 101
Avg Volume (10D) –
Key Metrics & Fundamentals
Market Cap
–
P/E Ratio
–
Div Yield
–%
52W Range
0.10 - 0.10
% vs 50 MA
–%
% vs 200 MA
–%
RSI-14
44.8
MACD Histogram
+0.0000
Beta (1Y vs SPY)
-0.86
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
VERAXA Biotech Designates Raju Willener as CFO
Exec Edge · Sep 9, 2026 3:46 PM
VERAXA Biotech (VRXA) Appoints Raju Willener as Chief Financial Officer
NewMediaWire · Sep 8, 2026 6:34 PM
VERAXA Biotech Appoints Raju Willener as Chief Financial Officer
GlobeNewswire · Sep 4, 2026 11:00 AM
VERAXA Biotech (VRXA), Secarna Partnership Milestone Opens New Potential Market for Conjugation Technology
NewMediaWire · Aug 28, 2026 7:00 PM
VERAXA Biotech (VRXA) Builds Antibody-Based Cancer Pipeline Around Dual-Targeting Precision
NewMediaWire · Aug 24, 2026 6:00 PM
VERAXA Biotech and Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate (AOC) Alliance
GlobeNewswire · Aug 24, 2026 11:00 AM
VERAXA Biotech (VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies
NewMediaWire · Aug 6, 2026 6:30 PM
VERAXA Biotech (VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform
NewMediaWire · Jul 30, 2026 6:15 PM
VERAXA Biotech (VRXA) Expands Patent Portfolio to Support Next-Generation Cancer Therapy Platforms
NewMediaWire · Jul 29, 2026 7:30 PM
VERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates
GlobeNewswire · Jul 29, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
No Reddit posts found for VRXAW.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.